Lyell Immunopharma (LYEL) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Lyell Immunopharma (LYEL) over the last 5 years, with Sep 2025 value amounting to -$19.9 million.
- Lyell Immunopharma's Other Gross PP&E Adjustments rose 45.69% to -$19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year increase of 303.65%. This contributed to the annual value of $84.1 million for FY2024, which is 18.66% down from last year.
- Per Lyell Immunopharma's latest filing, its Other Gross PP&E Adjustments stood at -$19.9 million for Q3 2025, which was up 4.96% from -$21.0 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments ranged from a high of $104.7 million in Q4 2022 and a low of -$48.4 million during Q2 2021.
- For the 3-year period, Lyell Immunopharma's Other Gross PP&E Adjustments averaged around -$10.4 million, with its median value being -$36.7 million (2024).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 184.33% in 2021, then declined by 18.66% in 2024.
- Over the past 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments (Quarterly) stood at $85.2 million in 2021, then climbed by 22.88% to $104.7 million in 2022, then declined by 1.24% to $103.4 million in 2023, then declined by 18.66% to $84.1 million in 2024, then spiked by 45.69% to -$19.9 million in 2025.
- Its last three reported values are -$19.9 million in Q3 2025, -$21.0 million for Q2 2025, and -$23.6 million during Q1 2025.